Edition: Global

Email: Passwd: or sign up now for free news alerts, archives

One News Page

85.4°F  •  Ashburn, VA  •  [Local News]

Ebola News

|<  Page 1  >>

	Inovio Pharma Reports On Preclinical Study Of SynCon DNA Vaccine WASHINGTON (dpa-AFX) - Inovio Pharmaceuticals Inc. (INO) announced that in a preclinical study of SynCon DNA vaccine against Ebola and Marburg filoviruses, the vaccine induced strong and broad imm... FinanzNachrichten.de 6 days ago Inovio Pharmaceuticals ([[INO]] +6.6%) pops after saying its SynCon DNA vaccine for the Marburg and Ebola viruses provides 100% protection against death. (PR) SeekingAlpha 6 days ago Inovio Pharmaceuticals DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study BLUE BELL, Pa., May 14, 2013 /PRNewswire/ --Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that in a preclinical study of Inovio's SynCon® DNA vaccine against Ebola and Marburg filov... FinanzNachrichten.de 6 days agoAlso reported by •PR Newswire Ringside Seat: Taxghazi Within hours after the news broke that the Internal Revenue Service singled out Tea Party and other conservative groups that had applied for tax-exempt 501(c)(4) status for extra scrutiny,.. The American Prospect 6 days ago NanoViricides, Inc. Brings in Experienced Executive as Interim CFO Filed under: Investing NanoViricides, Inc. Brings in Experienced Executive as Interim CFO WEST HAVEN, Conn.--(BUSINESS WIRE)-- NanoViricides, Inc. (OTC BB: NNVC) (the "Company") announced today.. DailyFinance 1 week ago This column will change your life: don't let your imaginary friends lead you astray 'When you conclude that you're having more or less sex than other people, remember those "others" exist, first and foremost, in your head' A few weeks back, as you'll probably recall, the media.. guardian.co.uk 1 week ago New insights into Ebola infection pave the way for much-needed therapies London, UK (SPX) May 10, 2013 The Ebola virus is among the deadliest viruses on the planet, killing up to 90% of those infected, and there are no approved vaccines or effective therapies. A study.. Terra Daily 1 week agoAlso reported by •Science Daily Tekmira (TKMR) says the Department of Defense has increased funding for the TKM-Ebola program by $6.9M to allow for the integration of "a more potent LNP formulation" and to improve manufacturing technology. The contract with the DOD (now at $41.7M) can b SeekingAlpha 2 weeks ago Tekmira Recieves $140M Government Contract for TKM-Ebola Program Tekmira Pharmaceuticals Corporation (Nasdaq: TKMR), a leading developer of RNA interference (RNAi) therapeutics, today announced that its contract with the U.S. Benzinga.com 2 weeks ago The fight back against Ebola In part of the struggle against the Ebola virus, scientists have discovered the mechanism behind one of the Ebola virus' most potent abilities: its ability to disarm the adaptive immune system. Digital Journal 2 weeks ago  |<  Page 1  >>
Our Facebook Page LIKE us now: Current Topics Oklahoma Wichita Fbi Agents Killed Weather Gas Prices White House Local News Ashburn area Staff Stories Saudi woman in record-breaking Everest climb Russia sends warships and deadly missile system to Syria as a warning to the west Scientists clone the first human embryonic stem cells Quantum computer to help pioneer breakthroughs in artificial intelligence BP and Shell raided by European regulators price-fixing inquiry

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy

© 2013 One News Page Ltd. All Rights Reserved.  |  About us  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation  RSS  |  News for my Website  |  Free news search widget  |  Advertise  |  Help  |  Contact us  |  DMCA / Content Removal How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+  Switch to U.S. version